Refine
Year of publication
- 2021 (69) (remove)
Document Type
- Article (37)
- Doctoral Thesis (17)
- Postprint (10)
- Conference Proceeding (3)
- Habilitation Thesis (2)
Is part of the Bibliography
- yes (69)
Keywords
- LC-MS/MS (5)
- Mitochondria (4)
- aging (4)
- inflammation (4)
- FGF21 (3)
- Insulin resistance (3)
- insulin (3)
- lipid metabolism (3)
- macrophages (3)
- manganese (3)
- metabolism (3)
- mitochondria (3)
- zinc (3)
- 1-aminodecylidene bis-phosphonic acid (2)
- Adipose tissue (2)
- Alterung (2)
- Beer (2)
- Bilophila wadsworthia (2)
- C. elegans (2)
- Cereals (2)
- Fettgewebe (2)
- Inflammatory bowel disease (2)
- Modified mycotoxins (2)
- Mycotoxins (2)
- Obesity (2)
- Pesticides (2)
- SDS PAGE (2)
- Tenebrio molitor larvae (2)
- VGCC (2)
- acid ceramidase (2)
- activated carbon (2)
- adipose tissue (2)
- bisphosphonates (2)
- brain insulin signaling (2)
- calcination (2)
- cell-based assay (2)
- cerami-des (2)
- cereal meals (2)
- coffee by-products (2)
- coronary heart disease (2)
- digestive enzymes quantification (2)
- elevated plus-maze (2)
- enzymology (2)
- fatty acid metabolism (2)
- feeding (2)
- fruit (2)
- functional inhibitors of acid sphin-gomyelinase (2)
- growth behavior (2)
- high-sodium (2)
- homeostasis (2)
- interleukin-8 (2)
- legumes (2)
- lysosomal hydrolases (2)
- lysosome (2)
- microwave assisted digestion (2)
- muscarinic acetylcholine receptor (2)
- neurotoxins (2)
- nut allergenic proteins (2)
- nuts (2)
- open-field (2)
- organic compounds adsorption (2)
- oxidative stress (2)
- parchment (2)
- post-natal (2)
- pre-natal (2)
- prostaglandin E2 (2)
- protein extraction (2)
- redox state (2)
- sample preparation (2)
- seeds (2)
- spent coffee grounds (2)
- sphingolipids (2)
- sphingomyelin (2)
- tryptic digestion (2)
- type 2 diabetes (2)
- valorization (2)
- vegetables (2)
- voltage-dependent calcium channels (2)
- α-amylase/trypsin inhibitors (2)
- 2D-LC-MS/MS (1)
- 3D breast cell model (1)
- AGE (1)
- Acid sphingomyelinase (1)
- Adipocytes (1)
- Adipositas (1)
- Advanced glycation end-products (1)
- Ageing (1)
- Akt (1)
- Alternative to animal testing (1)
- Ankle-brachial index (1)
- Arsenic (1)
- Arsenic speciation (1)
- Astrocytes (1)
- Augmentation (1)
- BBsome (1)
- BMI (1)
- Bbs4 (1)
- Botulinum neurotoxin (1)
- Botulinumtoxine (1)
- CRISPR/Cas9 (1)
- CVD (1)
- CXCR2 (1)
- Caenorhabditis elegans (1)
- Circadian rhythm (1)
- Contamination (1)
- Copper (1)
- DNA methylation (1)
- DNMT inhibitor (1)
- Diabetes (1)
- Diabetes-related vascular complications (1)
- Dietary sulfonates (1)
- EBI3 (1)
- Entzündung (1)
- Environmental (1)
- Food (1)
- GCN2 (1)
- GDF15 (1)
- Genetics (1)
- Genetik (1)
- Glucose homeostasis (1)
- Glucose intolerance (1)
- Glukoseintoleranz (1)
- Glycemia (1)
- HAMP (1)
- Heavy metals (1)
- Hepatocytes (1)
- High-resolution mass spectrometry (1)
- Honeydew honey (1)
- Hormones (1)
- Induced pluripotent stem cells (1)
- Inductively (1)
- Insulin (1)
- Insulin secretion (1)
- Insulinresistenz (1)
- Insulinsekretion (1)
- LC–MS/MS (1)
- LRP8 (1)
- Major royal jelly proteins (1)
- Makrophagen (1)
- Mangan (1)
- Marker peptides (1)
- Metabolisches Syndrom (1)
- Mitochondrien (1)
- Motor neurons (1)
- Motorneurone (1)
- Multi-Methods (1)
- Multi-method (1)
- Multi-mycotoxin analysis (1)
- Nahrungssulfonate (1)
- Nephropathy (1)
- Neuropathy (1)
- Nutrition (1)
- Nährstoffe (1)
- Occurrence data (1)
- PTEN (1)
- Prediabetes (1)
- Principal component analysis (1)
- Prostaglandin (1)
- Pulse wave velocity (1)
- RNAseq (1)
- ROS (1)
- Skeletal muscle cells (1)
- Skin (1)
- Sphingolipids (1)
- Spirulina (1)
- Spurenelement (1)
- Stoffwechsel (1)
- Stress response (1)
- Sulfonate (1)
- Sulfoquinovose (1)
- Susceptibility-genes (1)
- Suszeptibilitätsgene (1)
- T2D (1)
- TNF alpha (1)
- Taurocholate (1)
- Total arsenic (1)
- Toxicity (1)
- Trace elements (1)
- Typ-2-Diabetes (1)
- Type 2 diabetes (1)
- Type-2-diabetes (1)
- Ulcerative colitis (1)
- Uruguay River (1)
- Validation (1)
- Vascular stiffness (1)
- Weight change (1)
- Zink (1)
- Zytokine (1)
- acetate (1)
- alternative zu Tierversuchen (1)
- anorexia (1)
- appetite (1)
- appetite regulation (1)
- artificial (1)
- autofluorescence (1)
- autophagy (1)
- blood– brain barrier (1)
- blood– cerebrospinal fluid barrier (1)
- bone (1)
- brain (1)
- brain-gut axis (1)
- browning (1)
- burn injury (1)
- cancer stem cells (1)
- cardiokine (1)
- carotenoids (1)
- ceramide (1)
- chlorophylls (1)
- chronisch-entzündliche Darmerkrankungen (1)
- cilium (1)
- coupled plasma mass spectrometry (1)
- cytokine (1)
- cytokines (1)
- decitabine (1)
- dendritic polyglycerol (1)
- dietary patterns (1)
- dysfunction (1)
- endocrine disruption (1)
- energy expenditure (1)
- energy homeostasis (1)
- epigenetics (1)
- exercise (1)
- fatty acid synthesis (1)
- fatty liver (1)
- food choice (1)
- glasswort (1)
- gold nanostars (1)
- gut microbiota (1)
- halophytes (1)
- heptadecanoic acid (C17:0) (1)
- hyperglycemia (1)
- immune (1)
- index (1)
- induzierte pluripotente Stammzellen (1)
- inhibitory cytokines (1)
- insulin signalling (1)
- interleukin-35 (1)
- inulin (1)
- land-based aquaculture (1)
- low molecular weight selenium species (1)
- metabolic syndrom (1)
- methionine restriction (1)
- mitochondrial function (1)
- muscle (1)
- myokine (1)
- myopathy (1)
- neutrophil chemotaxis (1)
- nutrients (1)
- pentadecanoic acid (C15:0) (1)
- photothermal therapy (1)
- phthalates (1)
- phytochemicals (1)
- pollution (1)
- postprandial response (1)
- prebiotics (1)
- probiotics (1)
- propionate (1)
- prostaglandine (1)
- protein (1)
- protein restriction (1)
- reliability (1)
- retinoic acid (1)
- saline agriculture (1)
- salt (1)
- salt composition (1)
- sarcopenia (1)
- seawater (1)
- selenium (1)
- selenium transport (1)
- selenoprotein P (1)
- thermogenesis (1)
- trace element (1)
- type-2-diabetes (1)
- validity (1)
Institute
- Institut für Ernährungswissenschaft (69) (remove)
The mitochondrial chaperone complex HSP60/HSP10 facilitates mitochondrial protein homeostasis by folding more than 300 mitochondrial matrix proteins. It has been shown previously that HSP60 is downregulated in brains of type 2 diabetic (T2D) mice and patients,
causing mitochondrial dysfunction and insulin resistance. As HSP60 is also decreased in peripheral tissues in T2D animals, this thesis investigated the effect of overall reduced HSP60 in the development of obesity and associated co-morbidities.
To this end, both female and male C57Bl/6N control (i.e. without further alterations in their genome, Ctrl) and heterozygous whole-body Hsp60 knock-out (Hsp60+/-) mice, which exhibit a 50 % reduction of HSP60 in all tissues, were fed a normal chow diet (NCD) or a highfat diet (HFD, 60 % calories from fat) for 16 weeks and were subjected to extensive metabolic phenotyping including indirect calorimetry, NMR spectroscopy, insulin, glucose and pyruvate tolerance tests, vena cava insulin injections, as well as histological and molecular analysis.
Interestingly, NCD feeding did not result in any striking phenotype, only a mild increase in energy expenditure in Hsp60+/- mice. Exposing mice to a HFD however revealed an increased body weight due to higher muscle mass in female Hsp60+/- mice, with a simultaneous decrease in energy expenditure. Additionally, these mice displayed decreased fasting glycemia. Opposingly, male Hsp60+/- compared to control mice showed lower body weight gain due to decreased fat mass and an increased energy expenditure, strikingly independent of lean mass. Further, only male Hsp60+/- mice display improved HOMA-IR and Matsuda
insulin sensitivity indices.
Despite the opposite phenotype in regards to body weight development, Hsp60+/- mice of both sexes show a significantly higher cell number, as well as a reduction in adipocyte size in the subcutaneous and gonadal white adipose tissue (sc/gWAT). Curiously, this adipocyte hyperplasia – usually associated with positive aspects of WAT function – is disconnected from metabolic improvements, as the gWAT of male Hsp60+/- mice shows mitochondrial dysfunction, oxidative stress, and insulin resistance. Transcriptomic analysis of gWAT shows an up
regulation of genes involved in macroautophagy. Confirmatory, expression of microtubuleassociated protein 1A/1B light chain 3B (LC3), as a protein marker of autophagy, and direct measurement of lysosomal activity is increased in the gWAT of male Hsp60+/- mice.
In summary, this thesis revealed a novel gene-nutrient interaction. The reduction of the crucial chaperone HSP60 did not have large effects in mice fed a NCD, but impacted metabolism during DIO in a sex-specific manner, where, despite opposing body weight and
body composition phenotypes, both female and male Hsp60+/- mice show signs of protection from high fat diet-induced systemic insulin resistance.
The suitability of a newly developed cell-based functional assay was tested for the detection of the activity of a range of neurotoxins and neuroactive pharmaceuticals which act by stimulation or inhibition of calcium-dependent neurotransmitter release. In this functional assay, a reporter enzyme is released concomitantly with the neurotransmitter from neurosecretory vesicles. The current study showed that the release of a luciferase from a differentiated human neuroblastoma-based reporter cell line (SIMA-hPOMC1-26-GLuc cells) can be stimulated by a carbachol-mediated activation of the Gq-coupled muscarinic-acetylcholine receptor and by the Ca2+-channel forming spider toxin α-latrotoxin. Carbachol-stimulated luciferase release was completely inhibited by the muscarinic acetylcholine receptor antagonist atropine and α-latrotoxin-mediated release by the Ca2+-chelator EGTA, demonstrating the specificity of luciferase-release stimulation. SIMA-hPOMC1-26-GLuc cells express mainly L- and N-type and to a lesser extent T-type VGCC on the mRNA and protein level. In accordance with the expression profile a depolarization-stimulated luciferase release by a high K+-buffer was effectively and dose-dependently inhibited by L-type VGCC inhibitors and to a lesser extent by N-type and T-type inhibitors. P/Q- and R-type inhibitors did not affect the K+-stimulated luciferase release. In summary, the newly established cell-based assay may represent a versatile tool to analyze the biological efficiency of a range of neurotoxins and neuroactive pharmaceuticals which mediate their activity by the modulation of calcium-dependent neurotransmitter release.
The suitability of a newly developed cell-based functional assay was tested for the detection of the activity of a range of neurotoxins and neuroactive pharmaceuticals which act by stimulation or inhibition of calcium-dependent neurotransmitter release. In this functional assay, a reporter enzyme is released concomitantly with the neurotransmitter from neurosecretory vesicles. The current study showed that the release of a luciferase from a differentiated human neuroblastoma-based reporter cell line (SIMA-hPOMC1-26-GLuc cells) can be stimulated by a carbachol-mediated activation of the Gq-coupled muscarinic-acetylcholine receptor and by the Ca2+-channel forming spider toxin α-latrotoxin. Carbachol-stimulated luciferase release was completely inhibited by the muscarinic acetylcholine receptor antagonist atropine and α-latrotoxin-mediated release by the Ca2+-chelator EGTA, demonstrating the specificity of luciferase-release stimulation. SIMA-hPOMC1-26-GLuc cells express mainly L- and N-type and to a lesser extent T-type VGCC on the mRNA and protein level. In accordance with the expression profile a depolarization-stimulated luciferase release by a high K+-buffer was effectively and dose-dependently inhibited by L-type VGCC inhibitors and to a lesser extent by N-type and T-type inhibitors. P/Q- and R-type inhibitors did not affect the K+-stimulated luciferase release. In summary, the newly established cell-based assay may represent a versatile tool to analyze the biological efficiency of a range of neurotoxins and neuroactive pharmaceuticals which mediate their activity by the modulation of calcium-dependent neurotransmitter release.
Food intake is driven by the need for energy but also by the demand for essential nutrients such as protein. Whereas it was well known how diets high in protein mediate satiety, it remained unclear how diets low in protein induce appetite. Therefore, this thesis aims to contribute to the research area of the detection of restricted dietary protein and adaptive responses.
This thesis provides clear evidence that the liver-derived hormone fibroblast growth factor 21 (FGF21) is an endocrine signal of a dietary protein restriction, with the cellular amino acid sensor general control nonderepressible 2 (GCN2) kinase acting as an upstream regulator of FGF21 during protein restriction. In the brain, FGF21 is mediating the protein-restricted metabolic responses, e.g. increased energy expenditure, food intake, insulin sensitivity, and improved glucose homeostasis. Furthermore, endogenous FGF21 induced by dietary protein or methionine restriction is preventing the onset of type 2 diabetes in the New Zealand Obese mouse.
Overall, FGF21 plays an important role in the detection of protein restriction and macronutrient imbalance in rodents and humans, and mediates both the behavioral and metabolic responses to dietary protein restriction. This makes FGF21 a critical physiological signal of dietary protein restriction, highlighting the important but often overlooked impact of dietary protein on metabolism and eating behavior, independent of dietary energy content.
Investigation of Sirtuin 3 overexpression as a genetic model of fasting in hypothalamic neurons
(2021)
Diabetes is a major public health problem with increasing global prevalence. Type 2 diabetes (T2D), which accounts for 90% of all diagnosed cases, is a complex polygenic disease also modulated by epigenetics and lifestyle factors. For the identification of T2D-associated genes, linkage analyses combined with mouse breeding strategies and bioinformatic tools were useful in the past. In a previous study in which a backcross population of the lean and diabetes-prone dilute brown non-agouti (DBA) mouse and the obese and diabetes-susceptible New Zealand obese (NZO) mouse was characterized, a major diabetes quantitative trait locus (QTL) was identified on chromosome 4. The locus was designated non-insulin dependent diabetes from DBA (Nidd/DBA). The aim of this thesis was (i) to perform a detailed phenotypic characterization of the Nidd/DBA mice, (ii) to further narrow the critical region and (iii) to identify the responsible genetic variant(s) of the Nidd/DBA locus. The phenotypic characterization of recombinant congenic mice carrying a 13.6 Mbp Nidd/DBA fragment with 284 genes presented a gradually worsening metabolic phenotype. Nidd/DBA allele carriers exhibited severe hyperglycemia (~19.9 mM) and impaired glucose clearance at 12 weeks of age. Ex vivo perifusion experiments with islets of 13-week-old congenic mice revealed a tendency towards reduced insulin secretion in homozygous DBA mice. In addition, 16-week-old mice showed a severe loss of β-cells and reduced pancreatic insulin content. Pathway analysis of transcriptome data from islets of congenic mice pointed towards a downregulation of cell survival genes. Morphological analysis of pancreatic sections displayed a reduced number of bi-hormonal cells co-expressing glucagon and insulin in homozygous DBA mice, which could indicate a reduced plasticity of endocrine cells in response to hyperglycemic stress. Further generation and phenotyping of recombinant congenic mice enabled the isolation of a 3.3 Mbp fragment that was still able to induce hyperglycemia and contained 61 genes. Bioinformatic analyses including haplotype mapping, sequence and transcriptome analysis were integrated in order to further reduce the number of candidate genes and to identify the presumable causative gene variant. Four putative candidate genes (Ttc39a, Kti12, Osbpl9, Calr4) were defined, which were either differentially expressed or carried a sequence variant. In addition, in silico ChIP-Seq analyses of the 3.3 Mbp region indicated a high number of SNPs located in active regions of binding sites of β-cell transcription factors. This points towards potentially altered cis-regulatory elements that could be responsible for the phenotype conferred by the Nidd/DBA locus. In summary, the Nidd/DBA locus mediates impaired glucose homeostasis and reduced insulin secretion capacity which finally leads to β-cell death. The downregulation of cell survival genes and reduced plasticity of endocrine cells could further contribute to the β-cell loss. The critical region was narrowed down to a 3.3 Mbp fragment containing 61 genes, of which four might be involved in the development of the diabetogenic Nidd/DBA phenotype.